Bioxytran, Inc.
BIXT
$0.1567
-$0.0054-3.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 47.08% | 31.90% | -17.10% | -92.05% | -81.52% |
| Total Depreciation and Amortization | -4.82% | 62.96% | 102.22% | 206.25% | 130.56% |
| Total Amortization of Deferred Charges | 94.43% | -84.55% | -94.32% | 57.67% | 11.59% |
| Total Other Non-Cash Items | 187.54% | 4.58% | 2,607.76% | 1,173.22% | 261.46% |
| Change in Net Operating Assets | -61.70% | -15.73% | 75.29% | 274.16% | 953.82% |
| Cash from Operations | 92.80% | 77.07% | 53.50% | 48.96% | 57.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.12% | 42.71% | 24.14% | -212.33% | -37.58% |
| Cash from Investing | 36.12% | 42.71% | 24.14% | -212.33% | -37.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.55% | -90.89% | -37.31% | -18.47% | -19.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -200.00% | -- |
| Cash from Financing | -88.55% | -71.05% | -29.57% | -22.48% | -73.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.24% | 84.48% | 93.04% | 75.45% | -220.76% |